{"id":231058,"title":"Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T19:07:36.656000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/palivizumab-respiratory-syncitial-virus-infection-infants.html?wbdisable=false","snippet":"Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and…","rawSnapshotUrl":"/api/snapshots/raw/231058","browseUrl":"https://replay.healtharchive.ca/job-1/20250418190736/https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/palivizumab-respiratory-syncitial-virus-infection-infants.html?wbdisable=false#ha_snapshot=231058","mimeType":"text/html","statusCode":200}